Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial.
Laufman LR, Spiridonidis CH, Pritchard J, Roach R, Zangmeister J, Larrimer N, Moore T, Segal M, Jones J, Patel T, Gutterman L, Carman L, Colborn D, Kuebler JP.
Laufman LR, et al.
Ann Oncol. 2001 Sep;12(9):1259-64. doi: 10.1023/a:1012247311419.
Ann Oncol. 2001.
PMID: 11697837
Free article.
Clinical Trial.